Influence of Screen Sizes on Responses to Visual Analog Scales of Stress
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jul 30, 2019
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how the size of computer screens affects the way people respond to questions about stress using a tool called a visual analog scale (VAS). A VAS is a simple line where participants can mark how much stress they feel, ranging from not stressed at all (0) to very stressed (100). The researchers want to understand if using different screen sizes changes the way people fill out these stress questionnaires.
The study is currently looking for adult volunteers aged 65 to 74, and anyone who is willing to participate can join unless they have trouble understanding the questions or choose not to participate. If you join the trial, you will be asked to complete a questionnaire about your stress levels on different screen sizes. This research could help improve how stress is measured in the future, especially as more people use online tools for health assessments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult persons
- Exclusion Criteria:
- • Refusal to participate in the study
- • Unable to answer basic questions (difficulties understanding, cognitive disorders...)
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Patients applied
Trial Officials
frédéric Dutheil
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials